Insights From the informCLL Registry: Real-World Application of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

被引：0
|
作者：
Ghosh, Nilanjan [1 ]
Brander, Danielle [2 ]
Mato, Anthony R. [3 ]
Sharman, Jeff P. [4 ]
Gutierrez, Meghan [5 ]
Naganuma, Maoko [6 ]
Upasani, Sandhya [6 ]
Alagappan, Divi [7 ]
Huang, Qing [7 ]
Young, Alex [6 ]
Barrientos, Jacqueline C. [8 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
[2] Duke Univ Hlth Syst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Willamette Valley Canc Inst & Res Ctr, US Oncol Res, Eugene, OR USA
[5] Lymphoma Res Fdn, New York, NY USA
[6] Pharmacyclics LLC, Sunnyvale, CA USA
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Donald Barbara Zucker Sch Med Hofstra Northwell, Div Med Oncol & Hematol, Northwell Hlth Canc Inst, Lake Success, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CLL; CLL/SLL; real-world; registry; del(17p); TP53;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-074
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [41] Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China
    Ding, Kaiyang
    Cheng, Yue-Xin
    Wang, Xiaoyong
    Huang, Chen
    Liang, Yang
    Li, Wei
    Ye, Jingjing
    Ji, Chunyan
    BLOOD, 2023, 142
  • [42] Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Lei, Matthew M.
    Sorial, Mark N.
    Lou, Uvette
    Yu, Michelle
    Medrano, Andrea
    Ford, Josie
    Nemec, Ronald A.
    Abramson, Jeremy S.
    Soumerai, Jacob D.
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 653 - 659
  • [43] Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study
    Eyre, Toby A.
    Hess, Lisa M.
    Sugihara, Tomoko
    He, Dan
    Khanal, Manoj
    Pagel, John M.
    Walgren, Richard A.
    B. Abada, Paolo
    Konig, Heiko
    Roeker, Lindsey E.
    Mato, Anthony
    LEUKEMIA & LYMPHOMA, 2023, 64 (05) : 1005 - 1016
  • [44] Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Patterns Among Patients with Chronic or Small Lymphocytic Leukemia (CLL/SLL) in US Community Oncology Practices
    Hou, Jing-Zhou
    Blanc, Simon
    Maglinte, Gregory A.
    Vasudevan, Anupama
    Rui, Anna
    Gart, Michael
    Hoa Pham
    Aton, Lindsay
    Wang, Brandon
    Choksi, Rushir
    BLOOD, 2023, 142
  • [45] REAL-WORLD TREATMENT PATTERNS AND CARDIOVASCULAR DISEASE (CVD) BURDEN IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) RECEIVING COVALENT BRUTON'S TYROSINE KINASE INHIBITORS (CBTKIS)
    Dingli, D.
    de Nigris, E.
    Obeng-Kusi, M.
    Leng, S.
    Lodaya, K.
    Weimer, I
    Jiao, W.
    Hyatt, H.
    Yapici, H. O.
    VALUE IN HEALTH, 2024, 27 (06) : S241 - S241
  • [46] Clinical Monoclonal B Lymphocytosis (cMBL), Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): Diagnostic Criteria, Feature At Diagnosis and Natural History
    Santacruz, Rodrigo
    Delgado, Julio
    Baumann, Tycho
    Rozman, Maria
    Aymerich, Martha
    Pinyol, Magda
    Pereira, Arturo
    Royo, Cristina
    Navarro, Alba
    Lopez, Cristina
    Carrio, Anna
    Montserrat, Emili
    BLOOD, 2013, 122 (21)
  • [47] Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis
    Kittai, Adam S.
    Hang, Ying
    Bhat, Seema A.
    Clark, Abi
    Grever, Michael
    Rhodes, Joanna M.
    Roberts, Melyssa
    Rogers, Kerry A.
    Teschemaker, Anna
    Munoz-Sagastibelza, Maria
    Woyach, Jennifer A.
    Barrientos, Jacqueline C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (04) : 780 - 784
  • [48] AI-Based Clinical Decision Support System for Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Prediction of Treatment Efficiency
    Herishanu, Serenus. A. I.
    BLOOD, 2022, 140 : 12393 - 12394
  • [49] Real-world clinical outcomes in patients receiving either ibrutinib or chemoimmunotherapy (CIT) as first-line (1L) treatment for chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL): A retrospective analysis.
    Wu, Linda
    Ran, Tao
    He, Jinghua
    Panjabi, Sumeet
    Lu, Xiaoxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Real-World Outcomes of Chemoimmunotherapy in Chronic Lymphocytic Leukemia (CLL) Clinical Practice: Results from a Decade of Practice in Helsinki 2005-2015
    Lindstrom, Vesa
    Jarvinen, Tiina M.
    Mehtala, Juha
    Khanfir, Houssem
    Juuti, Rosa
    Leval, Amy
    Saily, Marjaana
    BLOOD, 2017, 130
12345